Online citations, reference lists, and bibliographies.
← Back to Search

Thermoresponsive Ophthalmic Poloxamer/tween/carbopol In Situ Gels Of A Poorly Water-soluble Drug Fluconazole: Preparation And In Vitro–in Vivo Evaluation

Wang Li-hong, Che Xin, Guo Yongxue, Bian Yiying, Cheng Gang
Published 2014 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Abstract The purpose of the present study was to optimize the formulations of the thermoresponsive ophthalmic in situ gels of a poorly water-soluble drug fluconazole (FLU) and evaluate the in vitro and in vivo properties of the formulations. The thermoresponsive ophthalmic FLU in situ gels were prepared by mixing FLU, Poloxamer407, Tween80, benzalkonium chloride and carbopol934 in borate buffer solution. The in vivo eye irritation tests and ophthalmic absorption were carried out in rabbits. The formulation compositions influenced the physicochemical properties of FLU in situ gels. The amount of poloxamer407 in the formulation was the main factor that affected the sol–gel transition temperature of the products. Tween80 not only improved the solubility of the FLU but also affected the products’ sol–gel transition temperature. In this study, sol–gel transition temperature was not affected by carbopol934. However, carbopol934 affected pH value, transparency and gelling capacity of the products. The product of the optimized formulation was a pseudoplastic fluid and its sol–gel transition temperature was 30.6 ± 1.2 °C. The autoclaving test showed that the sol–gel transition temperature, the flow ability and the flow behavior of the test samples did not change obviously after autoclaving sterilization at 121 °C and 15 psi for 20 min, thus the autoclaving was an acceptable sterilization method for this preparation. The thermoresponsive ophthalmic FLU in situ gels’ in vivo ophthalmic absorption was superior to the conventional FLU eye drop. In conclusion, the thermoresponsive ophthalmic FLU in situ gel is a better alternative than the FLU eye drop.
This paper references
10.1080/03639040701397241
Study on the Ocular Pharmacokinetics of Ion-Activated In Situ Gelling Ophthalmic Delivery System for Gatifloxacin by Microdialysis
Zhidong Liu (2007)
Chitosan nanoparticles for controlled delivery of brimonidine tartrate to the ocular membrane.
Singh Kh (2011)
10.1097/ICU.0b013e3283045e74
Contact lens-related microbial keratitis: recent outbreaks
A. Patel (2008)
Martin's physical pharmacy and pharmaceutical sciences : physical chemical and biopharmaceutical principles in the pharmaceutical sciences
A. Martin (2006)
10.3109/03639041003801885
Development of dorzolamide hydrochloride in situ gel nanoemulsion for ocular delivery
H. Ammar (2010)
10.1080/03639040500306203
Preparation and Evaluation of Sustained Ophthalmic Gel of Enoxacin
Zhidong Liu (2005)
Preparation of niosomes as an ocular delivery system for naltrexone hydrochloride: physicochemical characterization.
H. Abdelkader (2010)
10.3109/03639041003801893
Preparation and evaluation of in situ gelling ophthalmic drug delivery system for methazolamide
Yong Qian (2010)
10.1016/S0928-0987(97)00075-4
Rheological evaluation of poloxamer as an in situ gel for ophthalmic use.
K. Edsman (1998)
10.1016/j.ejpb.2008.04.010
Formulation and in vitro evaluation of cysteamine hydrochloride viscous solutions for the treatment of corneal cystinosis.
S. Bozdağ (2008)
10.1016/J.JCONREL.2007.07.009
In situ-forming hydrogels for sustained ophthalmic drug delivery.
Basavaraj K Nanjawade (2007)
Chitosan nanoparticles for controlled delivery of brimonidine tartrate to the ocular membrane.
Kavita H. Singh (2011)
Protein and peptide release from temperatureresponsive gels and thermogelling polymer matrices
L Bromberg (1998)
10.1080/03639040500214688
Release of Ciprofloxacin from Chondroitin 6-Sulfate-Graft-Poloxamer Hydrogel In Vitro for Ophthalmic Drug Delivery
M. Yoo (2005)
10.1016/J.JNNFM.2007.02.011
Carbopol gels: Elastoviscoplastic and slippery glasses made of individual swollen sponges: Meso- and macroscopic properties, constitutive equations and scaling laws
J.-M. Piau (2007)
10.3109/03639045.2012.707210
Development of in vitro models to demonstrate the ability of PecSys®, an in situ nasal gelling technology, to reduce nasal run-off and drip
J. Castile (2013)
Development of a novel ophthalmic ciclosporin A-loaded nanosuspension using top-down media milling methods.
J. Kim (2011)
10.1016/S0169-409X(97)00121-X
Temperature-responsive gels and thermogelling polymer matrices for protein and peptide delivery.
Ron (1998)
Pluronic poloxamer-g-poly (acrylic acid) copolymers as in situ gelling vehicle for ophthalmic drug delivery system
W Ma (2008)
10.1080/03639040500390934
Development of a Thermogelling Ophthalmic Formulation of Cysteine
G. Dumortier (2006)
10.1016/j.nano.2009.02.003
Nanomedicines for ocular NSAIDs: safety on drug delivery.
J. Araújo (2009)
10.1016/S0168-3659(02)00175-X
Thermosetting gels with modulated gelation temperature for ophthalmic use: the rheological and gamma scintigraphic studies.
Gang Wei (2002)
10.1016/S0168-3659(01)00279-6
Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system.
B. Srividya (2001)
Investigation of a new injectable thermosensitive hydrogel loading solid lipid nanoparticles.
Xinhong Guo (2011)
10.1080/03639040701580622
Temperature-responsive, Pluronic-g-poly(acrylic acid) copolymers in situ gels for ophthalmic drug delivery: rheology, in vitro drug release, and in vivo resident property.
Wen-di Ma (2008)
10.1080/03639040701580622
Temperature-Responsive, Pluronic-g-poly(acrylic acid) Copolymers In Situ Gels for Ophthalmic Drug Delivery: Rheology, In Vitro Drug Release, and In Vivo Resident Property
Wen-di Ma (2008)
10.3109/03639045.2010.522193
Preparation and evaluation of solid lipid nanoparticles of baicalin for ocular drug delivery system in vitro and in vivo
Zhidong Liu (2011)
10.1016/j.ejpb.2011.05.006
Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel.
T. Gratieri (2011)
10.1016/0378-5173(84)90022-X
Thermodynamic studies on the gel-sol transition of some pluronic polyols
M. Vadnere (1984)
10.1111/j.1439-0507.2008.01642.x
Aspergillus flavus: an emerging non‐fumigatus Aspergillus species of significance
S. Krishnan (2009)
10.1007/s11095-006-9104-4
A Review of Poloxamer 407 Pharmaceutical and Pharmacological Characteristics
G. Dumortier (2006)
Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations.
José Juan Escobar-Chávez (2006)
In vitro sustained release of recombinant human bone morphogenetic protein-2 microspheres embedded in thermosensitive hydrogels.
Y. Fu (2012)
10.3109/03639045.2012.665928
Improved initial burst of estradiol organogel as long-term in situ drug delivery implant: formulation, in vitro and in vivo characterization
Yang Yang (2012)
10.1016/S0168-3659(98)00189-8
Increased bioavailability of propranolol in rats by retaining thermally gelling liquid suppositories in the rectum.
J. M. Ryu (1999)
Melittin liposomes surface modified with poloxamer 188: in vitro characterization and in vivo evaluation.
Jilai Tian (2011)
10.1080/03639040701831710
In Situ Ophthalmic Gel of Ciprofloxacin Hydrochloride for Once a Day Sustained Delivery
S. Jain (2008)
10.1248/YAKUSHI.127.183
Preparation and evaluation of a Carbopol/HPMC-based in situ gelling ophthalmic system for puerarin.
C. Wu (2007)
10.1080/03639040701377433
A Long Acting Ophthalmic Gel Formulations of Atenolol
M. Hassan (2007)
10.1016/j.ijpharm.2011.03.054
Optimization and evaluation of thermoresponsive diclofenac sodium ophthalmic in situ gels.
Rathapon Asasutjarit (2011)
10.3109/03639041003718030
In vitro evaluation of gentamicin- and vancomycin-containing minitablets as a replacement for fortified eye drops
S. Bozdağ (2010)
10.1016/j.addr.2012.09.012
Thermosensitive sol-gel reversible hydrogels.
B. Jeong (2002)
Development and characterization of in situ gel system for nasal insulin delivery.
A. Agrawal (2010)
10.1111/j.1439-0507.2007.01480.x
Mycotic keratitis: an overview of diagnosis and therapy
P. Shukla (2008)
10.1016/J.EJPB.2007.02.025
Thermoresponsive hydrogels in biomedical applications.
Leda Klouda (2008)
Development and characterization of in situ gel system for nasal insulin
AK Agrawal (2010)
10.1080/03639040801958413
Ocular Drug Metabolism of the Bioactivating Antioxidant N-acetylcarnosine for Vision in Ophthalmic Prodrug and Codrug Design and Delivery
M. Babizhayev (2008)
10.1016/J.ADDR.2005.07.005
The use of mucoadhesive polymers in ocular drug delivery.
A. Ludwig (2005)
10.3109/03639040903099751
Mucoadhesive liposomes as ocular delivery system: physical, microbiological, and in vivo assessment
M. Mehanna (2010)
10.1080/03639040701831710
In situ ophthalmic gel of ciprofloxacin hydrochloride for once a day sustained delivery.
S. Jain (2008)
10.1111/j.1442-9071.2007.01417.x
Demographic pattern, predisposing factors and management of ulcerative keratitis: evaluation of one thousand unilateral cases at a tertiary care centre
A. Panda (2007)
10.3109/03639045.2012.707203
Design and development of a novel pH triggered nanoemulsified in-situ ophthalmic gel of fluconazole: Ex-vivo transcorneal permeation, corneal toxicity and irritation testing
M. Pathak (2013)
10.3109/03639045.2011.653813
In situ gelling properties of anionic thiomers
Fabian Hintzen (2012)
10.1021/JS980222J
Evaluation of pluronic F127-based sustained-release ocular delivery systems for pilocarpine using the albino rabbit eye model.
S. D. Desai (1998)
10.1016/J.IJPHARM.2006.12.038
Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin.
Hongyi Qi (2007)
10.1016/J.IJPHARM.2007.09.005
Pluronic F127-g-poly(acrylic acid) copolymers as in situ gelling vehicle for ophthalmic drug delivery system.
Wen-di Ma (2008)



This paper is referenced by
10.1007/978-3-319-95807-1_23
Thermoresponsive Gel Drug Delivery for Retina and Posterior Segment Disease
Komal Parmar (2018)
10.3109/10837450.2015.1026607
Thermosensitive in situ nanogel as ophthalmic delivery system of curcumin: development, characterization, in vitro permeation and in vivo pharmacokinetic studies
R. Liu (2016)
10.1016/j.jddst.2019.101373
Formulation and optimization of microemulsion based sparfloxacin in-situ gel for ocular delivery: In vitro and ex vivo characterization
Mori Dhaval (2020)
Progress in In-situ Gelling Ophthalmic Drug Delivery System
Yumei Wu (2018)
10.3109/03639045.2015.1040417
Viscoelastic interactions between polydeoxyribonucleotide and ophthalmic excipients
Iksoo Kim (2016)
10.1016/J.JDDST.2016.03.009
A novel cationic nanostructured lipid carrier for improvement of ocular bioavailability: Design, optimization, in vitro and in vivo evaluation
R. Liu (2016)
10.1016/j.colsurfb.2018.11.065
In-situ forming gels containing fluorometholone-loaded polymeric nanoparticles for ocular inflammatory conditions.
Roberto González-Pizarro (2019)
10.1016/j.ijbiomac.2016.05.016
The potential application of hyaluronic acid coated chitosan nanoparticles in ocular delivery of dexamethasone.
M. A. Kalam (2016)
10.1016/j.ajps.2019.09.003
A stepwise optimization strategy to formulate in situ gelling formulations comprising fluconazole-hydroxypropyl-beta-cyclodextrin complex loaded niosomal vesicles and Eudragit nanoparticles for enhanced antifungal activity and prolonged ocular delivery
H. Elmotasem (2019)
10.1016/BS.MIM.2019.01.001
Biocompatible in-situ gelling polymer hydrogels for treating ocular infection
M. Sharma (2019)
10.1016/j.drudis.2019.05.036
Poloxamer-based in situ gelling thermoresponsive systems for ocular drug delivery applications.
K. Soliman (2019)
10.1016/j.ejpb.2017.01.023
In vivo eye surface residence determination by high‐resolution scintigraphy of a novel ion‐sensitive hydrogel based on gellan gum and kappa‐carrageenan
Anxo Fernández-Ferreiro (2017)
10.1016/j.ajps.2018.04.008
Research progress of in-situ gelling ophthalmic drug delivery system
Yumei Wu (2019)
10.1016/j.ijbiomac.2016.04.070
Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone.
M. A. Kalam (2016)
10.1016/j.carbpol.2018.06.086
Carrageenan based hydrogels for drug delivery, tissue engineering and wound healing.
Ramanathan Yegappan (2018)
10.1002/9781119640240.ch11
Vaginal Bioadhesive Drug Delivery Systems and Their Applications
Anju Sharma (2020)
10.1016/j.ijpharm.2018.05.040
Gel in core carbosomes as novel ophthalmic vehicles with enhanced corneal permeation and residence
Mona A Moustafa (2018)
10.3109/03639045.2015.1066798
Mucoadhesive nano-sized supramolecular assemblies for improved pre-corneal drug residence time
A. Fabiano (2015)
10.22159/IJAP.2018V10I4.26885
OPHTHALMIC IN-SITU SUSTAINED GEL OF CIPROFLOXACIN, PREPARATION AND EVALUATION STUDY
Fadia Yassir Al-bazzaz (2018)
Semantic Scholar Logo Some data provided by SemanticScholar